Interaction between blood-brain barrier and glymphatic system in solute clearance

被引:97
作者
Verheggen, I. C. M. [1 ]
Van Boxtel, M. P. J. [1 ]
Verhey, F. R. J. [1 ]
Jansen, J. F. A. [2 ]
Backes, W. H. [2 ]
机构
[1] Maastricht Univ, Dept Psychiat & Neuropsychol, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Sch Mental Hlth & Neurosci, POB 5800, NL-6202 AZ Maastricht, Netherlands
关键词
Blood-brain barrier; BBB; Glymphatic system; Clearance; Amyloid-beta; Alzheimer's disease; Imaging; SMALL VESSEL DISEASE; AMYLOID CASCADE HYPOTHESIS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; MOUSE MODEL; BETA-PEPTIDE; A-BETA; TRANSPORT; DEMENTIA;
D O I
10.1016/j.neubiorev.2018.03.028
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Neurovascular pathology concurs with protein accumulation, as the brain vasculature is important for waste clearance. Interstitial solutes, such as amyloid-beta, were previously thought to be primarily cleared from the brain by blood-brain barrier transport. Recently, the glymphatic system was discovered, in which cerebrospinal fluid is exchanged with interstitial fluid, facilitated by the aquaporin-4 water channels on the astroglial endfeet. Glymphatic flow can clear solutes from the interstitial space. Blood-brain barrier transport and glymphatic clearance likely serve complementary roles with partially overlapping mechanisms providing a well-conditioned neuronal environment. Disruption of these mechanisms can lead to protein accumulation and may initiate neurodegenerative disorders, for instance amyloid-beta accumulation and Alzheimer's disease. Although both mechanisms seem to have a similar purpose, their interaction has not been clearly discussed previously. This review focusses on this interaction in healthy and pathological conditions. Future health initiatives improving waste clearance might delay or even prevent onset of neurodegenerative disorders. Defining glymphatic flow kinetics using imaging may become an alternative way to identify those at risk of Alzheimer's disease.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 50 条
  • [1] Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier
    Bachmeier, Corbin
    Beaulieu-Abdelahad, David
    Mullan, Michael
    Paris, Daniel
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 124 - 129
  • [2] The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases
    Braun, Molly
    Iliff, Jeffrey J.
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 413 - 436
  • [3] Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction
    Gireud-Goss, Monica
    Mack, Alexis F.
    McCullough, Louise D.
    Urayama, Akihiko
    NEUROSCIENTIST, 2021, 27 (06) : 668 - 684
  • [4] Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease
    Wang, Dong
    Chen, Fanglian
    Han, Zhaoli
    Yin, Zhenyu
    Ge, Xintong
    Lei, Ping
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [5] Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood-brain barrier
    Wang, Xiang
    Yin, Yue
    Zhou, Huaijuan
    Chi, Bowen
    Guan, Ling
    Li, Pei
    Li, Jinhua
    Wang, Yilong
    EXPLORATION, 2024,
  • [6] Drug delivery to the brain in Alzheimer's disease: Consideration of the blood-brain barrier
    Banks, William A.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 629 - 639
  • [7] The dynamic blood-brain barrier
    Keaney, James
    Campbell, Matthew
    FEBS JOURNAL, 2015, 282 (21) : 4067 - 4079
  • [8] Limitations of the hCMEC/D3 Cell Line as a Model for Aβ Clearance by the Human Blood-brain Barrier
    Biemans, Elisanne A. L. M.
    Jakel, Lieke
    de Waal, Robert M. W.
    Kuiperij, H. Bea
    Verbeek, Marcel M.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (07) : 1513 - 1522
  • [9] The glymphatic system and meningeal lymphatics of the brain: new understanding of brain clearance
    Yankova, Galina
    Bogomyakova, Olga
    Tulupov, Andrey
    REVIEWS IN THE NEUROSCIENCES, 2021, 32 (07) : 693 - 705
  • [10] PCSK9 acts as a key regulator of Aβ clearance across the blood-brain barrier
    Mazura, Alexander D.
    Ohler, Anke
    Storck, Steffen E.
    Kurtyka, Magdalena
    Scharfenberg, Franka
    Weggen, Sascha
    Becker-Pauly, Christoph
    Pietrzik, Claus U.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (04)